EUVIMEDEUVIMED entdecken
Crossref

Plasmid- and Inducer-Free Biosynthesis of Difucosyllactose through Rational Fusion Enzyme Engineering and Systematic Pathway Optimization

Zhiqiang Liu, Binglin Li, Jieying Deng, Yanfeng Liu iD, Jianghua Li, Guocheng Du, Jian Chen, Xueqin Lv iD, Xianhao Xu, Long Liu iD

ACS Synthetic Biology · 2026

DOI: 10.1021/acssynbio.6c00229 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Synthetic Biology, 2026. Verfasst von Zhiqiang Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, Jiangnan University, Wuxi214122, China. Hauptthemen laut MEDLINE: Escherichia coli, Plasmids, Trisaccharides, Metabolic Engineering. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Key Technological Project of Jiangxi Province, National Basic Research Program of China (973 Program).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Difucosyllactose (DFL), a fucosylated human milk oligosaccharide, exhibits significant application potential in the food and pharmaceutical industries. However, the microbial production of DFL faces challenges such as the accumulation of the intermediate 2′-fucosyllactose (2′-FL) and the high costs associated with the use of antibiotics and inducers. In this study, we constructed a plasmid- and inducer-free Escherichia coli MG1655 strain to enhance the biosynthesis of DFL while minimizing 2′-FL accumulation. Initially, the de novo DFL biosynthetic pathway was established by introducing different α-1,3-fucosyltransferases (α-1,3-FucT) into a 2′-FL-producing strain. Combinatorial metabolic engineering strategies were then employed to improve DFL accumulation. Subsequently, guided by the in silico multienzyme assembling by reshaping space (iMARS) framework, a fusion enzyme, FucTaY218K-L60-FutC, was rationally designed to effectively alleviate 2′-FL accumulation. Furthermore, modulation of the hydrophobic microenvironment in the substrate-binding pocket of FucTaY218K yielded the beneficial mutant FucTaY218K/W31R. Finally, modifications to the lactose operon significantly improved strain growth while concurrently enhancing DFL production. The best-performing strain achieved a DFL titer of 74 g/L in a 5-L bioreactor, corresponding to a productivity of 0.96 g/L/h, representing the highest productivity reported to date. This study establishes a robust and environmentally friendly platform for the industrial-scale production of DFL and provides a strategy for the microbial synthesis of other high-value human milk oligosaccharides.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coliPlasmidsTrisaccharidesMetabolic EngineeringFucosyltransferasesRecombinant Fusion Proteins

Stichwörter der Autor:innen

Escherichia colide novo synthesisdifucosyllactoseenzyme engineeringfusion enzyme

Substanzen

Trisaccharides2'-fucosyllactoseFucosyltransferasesRecombinant Fusion Proteins

Autor:innen und Institutionen

  • Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, Jiangnan University, Wuxi214122, China.
  • Science Center for Future Foods, Jiangnan University, Wuxi214122, China.

ORCID-Profile: Yanfeng Liu, Xueqin Lv, Long Liu

Förderung

  • Fundamental Research Funds for the Central Universities
  • Key Technological Project of Jiangxi Province
  • National Basic Research Program of China (973 Program)
  • National Natural Science Foundation of China (NSFC)
  • Jiangsu Basic Research Center for Synthetic Biology

Zitieren

APA

Liu, Z., Li, B., Deng, J., Liu, Y., Li, J., Du, G., Chen, J., Lv, X., Xu, X., & Liu, L. (2026). Plasmid- and Inducer-Free Biosynthesis of Difucosyllactose through Rational Fusion Enzyme Engineering and Systematic Pathway Optimization. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.6c00229

Vancouver

Liu Z, Li B, Deng J, Liu Y, Li J, Du G, et al. Plasmid- and Inducer-Free Biosynthesis of Difucosyllactose through Rational Fusion Enzyme Engineering and Systematic Pathway Optimization. ACS Synthetic Biology. 2026. doi:10.1021/acssynbio.6c00229

BibTeX
@article{Liu2026,
  author = {Liu, Zhiqiang and Li, Binglin and Deng, Jieying and Liu, Yanfeng and Li, Jianghua and Du, Guocheng and Chen, Jian and Lv, Xueqin and Xu, Xianhao and Liu, Long},
  title = {Plasmid- and Inducer-Free Biosynthesis of Difucosyllactose through Rational Fusion Enzyme Engineering and Systematic Pathway Optimization},
  journal = {ACS Synthetic Biology},
  year = {2026},
  doi = {10.1021/acssynbio.6c00229}
}
Kostenlos starten →